Quality of life of Bahraini women with breast cancer: a cross sectional study

BMC Cancer

Ghufran Ahmed Jassim¹  David L Whitford¹ 

[1] Royal College of Surgeons in Ireland-Medical University of Bahrain, PO Box 15503, Adliya, Bahrain

关键词: EORTC;    Middle East;    Bahraini women;    Quality of life;    Bahrain;    Breast cancer;   

Others  :  1079779
DOI  :  10.1186/1471-2407-13-212

 received in 2013-01-01, accepted in 2013-04-23,  发布年份 2013

【 摘 要 】

Background

Breast cancer can impact survivors in many aspects of their life. Scarce information is currently available on the quality of life of cancer survivors in Bahrain. The objective of this study is to describe the quality of life of Bahraini women with breast cancer and its association with their sociodemographic and clinical data.

Methods

This is a cross sectional study in which the European Organization for Research and Treatment of Cancer Quality of Life Cancer Specific version translated into Arabic was administered to a random sample of 337 Bahraini women with breast cancer. Relevant descriptive statistics were computed for all items. The equality of means across the categories of each categorical independent variable was tested using parametric tests (ANOVA and independent t-test) or non-parametric tests (Kruskal Wallis and Mann Whitney tests) of association where appropriate.

Results

Of the total sample, 239 consented to participation. The mean and median age of participants were 50.2 (SD ± 11.1) and 48.0 respectively. Participants had a mean score for global health of 63.9 (95% CI 61.21-66.66). Among functional scales, social functioning scored the highest (Mean 77.5 [95% CI 73.65-81.38]) whereas emotional functioning scored the lowest (63.4 [95% CI 59.12-67.71]). The most distressing symptom on the symptom scales was fatigability (Mean 35.2 [95% CI 31.38-39.18]). Using the disease specific tool it was found that sexual functioning scored the lowest (Mean 25.9 [95% CI 70.23-77.90]). On the symptom scale, upset due to hair loss scored the highest (Mean 46.3 [95% CI 37.82-54.84]). Significant mean differences were noted for many functional and symptom scales.

Conclusion

Bahraini breast cancer survivors reported favorable overall global quality of life. Factors associated with a major reduction in all domains of quality of life included the presence of metastases, having had a mastectomy as opposed to a lumpectomy and a shorter time elapsed since diagnosis. Poorest functioning was noted in the emotional and sexual domains. The most bothersome symptoms were fatigability, upset due to hair loss and arm symptoms. This study identifies the categories of women at risk of poorer quality of life after breast cancer and the issues that most need to be addressed in this Middle East society.

【 授权许可】

   
2013 Jassim and Whitford; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Globocan cancer fact sheet: Breast Cancer Incidence and Mortality Worldwide in 2008, Summary. 2008. http://globocan.iarc.fr/factsheets/cancers/breast.asp webcite
• [2]Ferlay, Bray, Pisan: Globocan 2002: cancer Incidence, mortality and prevalence world wide version 2.0: IARC Cancer Base no. 5. Lyon: IARCPress; 2004.
• [3]Najjar H, Easson A: "Age at diagnosis of breast cancer in Arab nations". Int J Surg 2010, 8(6):448-452.
• [4]Alsayyad J, Hamadeh R: Cancer incidence among the Bahraini population: a five-year (1998–2002) experience. Ann Saudi Med 2007, 27(4):251-258.
• [5]Fakhro AE, Fateha BE, al-Asheeri N, al-Ekri SA: Breast cancer: patient characteristics and survival analysis at Salmaniya medical complex, Bahrain. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 1999, 5(3):430-439.
• [6]Chiedozi LC, El-Hag IA, Kollur SM: Breast diseases in the Northern region of Saudi Arabia. Saudi Med J 2003, 24(6):623-627.
• [7]Abu-Naser D: Arab women who have breast cancer face taboo. The associated Press; 2007. Available at http://www.nbcnews.com/id/21455455/ns/health-cancer/t/breast-cancer-often-untreated-middle-east/ webcite
• [8]Health statistics. http://www.moh.gov.bh/PDF/Publications/Statistics/HS2009/PDF/CH02-census_2008.pdf webcite
• [9]Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85(5):365-376.
• [10]Awad MA, Denic S, El Taji H: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking Populations. Ann N Y Acad Sci 2008, 1138:146-154.
• [11]EORTC group for research into Quality of life/Manuals. http://groups.eortc.be/qol/manuals webcite
• [12]Fayers PM: Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. Eur J Cancer 2001, 37(11):1331-1334.
• [13]Ahn SH, Park BW, Noh DY, Nam SJ, Lee ES, Lee MK, Kim SH, Lee KM, Park SM, Yun YH: Health-related quality of life in disease-free survivors of breast cancer with the general population. Ann Oncol 2007, 18(1):173-182.
• [14]Waldmann A, Pritzkuleit R, Raspe H, Katalinic A: The OVIS study: health related quality of life measured by the EORTC QLQ-C30 and -BR23 in German female patients with breast cancer from Schleswig-Holstein. Qual Life Res 2007, 16(5):767-776.
• [15]Hopwood P, Haviland J, Mills J, Sumo G, MB J: The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). Breast 2007, 16(3):241-251.
• [16]Montazeri A, Vahdaninia M, Harirchi I, Ebrahimi M, Khaleghi F, Jarvandi S: Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up study. BMC Cancer 2008, 8:330. BioMed Central Full Text
• [17]Alawadi SA, Ohaeri JU: Health - related quality of life of Kuwaiti women with breast cancer: a comparative study using the EORTC Quality of Life Questionnaire. BMC Cancer 2009, 9:222. BioMed Central Full Text
• [18]Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H: Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer. J Clin Oncol 2005, 23(22):4945-4953.
• [19]Casso D, Buist DS, Taplin S: Quality of life of 5–10 year breast cancer survivors diagnosed between age 40 and 49. Health Qual Life Outcomes 2004, 2:25. BioMed Central Full Text
• [20]Lipson JG, Meleis AI: Issues in health care of Middle Eastern patients. West J Med 1983, 139(6):854-861.
• [21]King MT, Fayers PM: Making quality-of-life results more meaningful for clinicians. Lancet 2008, 371(9614):709-710.
• [22]Schwarz R, Hinz A: Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001, 37(11):1345-1351.
• [23]Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR: Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002, 77(4):371-383.
• [24]Fobair P, Stewart SL, Chang S, D’Onofrio C, Banks PJ, Bloom JR: Body image and sexual problems in young women with breast cancer. Psychooncology 2006, 15(7):579-594.
• [25]Mols F, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV: Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer 2005, 41(17):2613-2619.
• [26]Sbitti Y, Kadiri H, Essaidi I, Fadoukhair Z, Kharmoun S, Slimani K, Ismaili N, Ichou M, Errihani H: Breast cancer treatment and sexual dysfunction: Moroccan women’s perception. BMC Womens Health 2011, 11:29. BioMed Central Full Text
• [27]Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA: Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol 2003, 21(21):4027-4033.
• [28]Kwan ML, Ergas IJ, Somkin CP, Quesenberry CP Jr, Neugut AI, Hershman DL, Mandelblatt J, Pelayo MP, Timperi AW, Miles SQ: Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat 2010, 123(2):507-524.
• [29]Cimprich B, Ronis DL, Martinez-Ramos G: Age at diagnosis and quality of life in breast cancer survivors. Cancer Pract 2002, 10(2):85-93.
• [30]Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D: Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study. Breast J 2004, 10(3):223-231.
• [31]van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K, Bartelink H: Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial. J Natl Cancer Inst 2000, 92(14):1143-1150.
• [32]Buijs C, de Vries EG, Mourits MJ, Willemse PH: The influence of endocrine treatments for breast cancer on health-related quality of life. Cancer Treat Rev 2008, 34(7):640-655.
• [33]Kornblith AB, Herndon JE 2nd, Weiss RB, Zhang C, Zuckerman EL, Rosenberg S, Mertz M, Payne D, Jane Massie M, Holland JF: Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer 2003, 98(4):679-689.
• [34]Peuckmann V, Ekholm O, Sjogren P, Rasmussen NK, Christiansen P, Moller S, Groenvold M: Health care utilisation and characteristics of long-term breast cancer survivors: nationwide survey in Denmark. Eur J Cancer 2009, 45(4):625-633.
• [35]Safaee A, Moghimi-Dehkordi B, Zeighami B, Tabatabaee H, Pourhoseingholi M: Predictors of quality of life in breast cancer patients under chemotherapy. Indian J Cancer 2008, 45(3):107-111.
• [36]Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, Meyerowitz BE, Bower JE, Belin TR: Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst 2004, 96(5):376-387.